Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.03% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 6.96% |
| 4 | Financials | 6.02% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
PUT
Parker-Hannifin
PH
$125B
| $3.5M | ﹤0.01% |
6,300
+5,600
| +800% | +$2.85M |
|
3127
BRC Inc
BRCC
$120M
| $3.49M | ﹤0.01% |
+81,640
| New | +$3.39M |
|
3128
Regenxbio
RGNX
$638M
| $3.49M | ﹤0.01% |
165,821
+110,498
| +200% | +$1.97M |
|
3129
Domo
DOMO
$182M
| $3.48M | ﹤0.01% |
390,160
+108,521
| +39% | +$1.13M |
|
3130
Sprouts Farmers Market
SFM
$7.6B
| $3.48M | ﹤0.01% |
53,960
-84,241
| -61% | -$4.69M |
|
3131
Walker & Dunlop
WD
$1.42B
| $3.48M | ﹤0.01% |
+34,411
| New | +$3.3M |
|
3132
Selective Insurance
SIGI
$5.51B
| $3.48M | ﹤0.01% |
31,849
-90,933
| -74% | -$9.37M |
|
3133
NCR Voyix
VYX
$1.21B
| $3.47M | ﹤0.01% |
274,767
-362,637
| -57% | -$5.22M |
|
|
LOMA
3134
Loma Negra
LOMA
$1.13B
| $3.47M | ﹤0.01% |
519,291
+29,639
| +6% | +$201K |
|
3135
PUT
Kenvue
KVUE
$36.8B
| $3.47M | ﹤0.01% |
161,500
-411,000
| -72% | -$8.34M |
|
3136
Customers Bancorp
CUBI
$2.65B
| $3.47M | ﹤0.01% |
65,307
-16,257
| -20% | -$856K |
|
|
PARA
3137
PUT
DELISTED
Paramount Global Class B
PARA
| $3.45M | ﹤0.01% |
293,500
+232,700
| +383% | +$2.93M |
|
3138
PUT
Encompass Health
EHC
$11.9B
| $3.45M | ﹤0.01% |
+41,800
| New | +$3.06M |
|
3139
908 Devices
MASS
$444M
| $3.45M | ﹤0.01% |
456,388
+431,910
| +1,764% | +$3.2M |
|
|
SWTX
3140
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $3.45M | ﹤0.01% |
+70,000
| New | +$3.24M |
|
3141
Textron
TXT
$14.3B
| $3.44M | ﹤0.01% |
35,887
-912,815
| -96% | -$79M |
|
3142
National Vision
EYE
$1.37B
| $3.44M | ﹤0.01% |
155,045
+9,299
| +6% | +$196K |
|
3143
Designer Brands
DBI
$279M
| $3.44M | ﹤0.01% |
314,304
+173,687
| +124% | +$1.66M |
|
3144
Autohome
ATHM
$2.63B
| $3.43M | ﹤0.01% |
+130,837
| New | +$3.4M |
|
|
ELEV
3145
DELISTED
Elevation Oncology
ELEV
| $3.43M | ﹤0.01% |
668,573
-2,321,706
| -78% | -$7.52M |
|
|
DRD
3146
DRDGold
DRD
$2.5B
| $3.41M | ﹤0.01% |
416,399
-582,661
| -58% | -$4.42M |
|
3147
ICU Medical
ICUI
$4.38B
| $3.41M | ﹤0.01% |
31,806
+14,067
| +79% | +$1.4M |
|
3148
CEMIG Preferred Shares
CIG
$5.69B
| $3.41M | ﹤0.01% |
1,792,339
-3,338,007
| -65% | -$5.98M |
|
3149
Savers
SVV
$1.62B
| $3.4M | ﹤0.01% |
176,286
-23,638
| -12% | -$441K |
|
3150
Calix
CALX
$2.36B
| $3.4M | ﹤0.01% |
102,414
+30,079
| +42% | +$1.12M |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander's Q1 2024 filing shows 858 new, 2,292 increased, 2,484 reduced and 745 closed positions. Its largest new stake was iShares Bitcoin Trust: 20,859,447 shares worth $844M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.